RUA Life Sciences Plc

RUA Life Sciences Plc RUA

Dividend Summary



There have not been any declared dividends recently.

Latest Dividends
Summary Previous dividend Next dividend
Status
Type
Per share
Declaration date
Ex-div date
Pay date

Enter the number of RUA Life Sciences Plc shares you hold and we'll calculate your dividend payments:

Previous Payment
Next Payment
Forecast Accuracy
We have not made any dividend predictions for RUA Life Sciences Plc
Dividend Yield Today
0.0%
The dividend yield is calculated by dividing the annual dividend payment by the prevailing share price
The table below shows the full dividend history for RUA Life Sciences Plc
Status Type Decl. date Ex-div date Pay date Decl. Currency Forecast amount Decl. amount Accuracy
There are no RUA Life Sciences Plc dividends.
Year Amount Change
2006 0.0p
2007 0.0p
0%
2008 0.0p
0%
2009 0.0p
0%
2010 0.0p
0%
2011 0.0p
0%
2012 0.0p
0%
2013 0.0p
0%
2014 0.0p
0%
2015 0.0p
0%
2016 0.0p
0%
2017 0.0p
0%
2018 0.0p
0%
2019 0.0p
0%
2020 0.0p
0%
2021 0.0p
0%
2022 0.0p
0%
2023 0.0p
0%
2024 Sign Up Required

RUA Life Sciences Plc Optimized Dividend Chart

The chart below shows the optimized dividends for this security over a rolling 12-month period.
Dividend Yield Today
0.0%
Optimized Yield
Sign Up Required
52 Week High
0.0% on 24 November 2023
52 Week Low
0.0% on 24 November 2023
Next Ex-Div-Date Countdown
Sign Up Required

About RUA Life Sciences Plc

RUA Life Sciences PLC, formerly AorTech International plc, is a biomaterials and medical device intellectual property (IP) company. The Company is focused on the commercialization of its biomedical polymer technology, components and medical devices. The Company has developed biostable, implantable polymers, including Elast-Eon and ECSil, which are long-term implantable co-polymers. Its Elast-Eon technology is available in a range of mechanical properties (Elastomers to rigid polymers), 70 Shore A to 80 Shore D. Its ECSil technology is available in a range of mechanical properties, but extends the softer materials to 70 Shore A. The Company has developed Elast-Eon and Reaction Injection Molding (RIM) technology for use in high-precision medical device components. Its polymers are developed and used in cardiology and urological applications, including pacing leads, cardiac cannulae, stents and neuro stimulation devices.

Sector
Health Care Equipment & Services
Country
United Kingdom
Share Price
£0.12 (yesterday's closing price)
Shares in Issue
66 million
Market Cap
£8mn
CADI
The Consecutive Annual Dividend Increases - the number of years this company has been increasing its dividends
0
Market Indices
none
No articles found